BiotechTube
Tong Ren Tang

Tong Ren Tang

600085.SS
China

Beijing Tong Ren Tang Co., Ltd. is a 350+ year old Chinese pharmaceutical giant specializing in traditional Chinese medicine, with a rich heritage dating back to the Qing Dynasty when it served as the imperial pharmacy. The company has successfully modernized its operations while preserving traditional formulations, operating manufacturing facilities, retail chains, and export businesses across multiple countries. As a publicly traded company on the Shanghai Stock Exchange, Tong Ren Tang represents the commercialization of TCM on a global scale, combining centuries-old wisdom with contemporary quality standards and distribution networks.

tongrentang.com

600085.SS · Stock Price

USD 28.608.34 (-22.58%)
Market Cap: $5.7B

Historical price data

AI Company Overview

Beijing Tong Ren Tang Co., Ltd. is a 350+ year old Chinese pharmaceutical giant specializing in traditional Chinese medicine, with a rich heritage dating back to the Qing Dynasty when it served as the imperial pharmacy. The company has successfully modernized its operations while preserving traditional formulations, operating manufacturing facilities, retail chains, and export businesses across multiple countries. As a publicly traded company on the Shanghai Stock Exchange, Tong Ren Tang represents the commercialization of TCM on a global scale, combining centuries-old wisdom with contemporary quality standards and distribution networks.

Traditional Chinese MedicineCardiovascularRespiratoryNeurologicalGeneral WellnessDigestive Health

Technology Platform

Traditional Chinese Medicine formulations combined with modern pharmaceutical manufacturing and quality control systems, preserving 350+ years of herbal medicine expertise while meeting contemporary safety and efficacy standards.

Opportunities

Significant growth potential through international expansion of TCM products, increasing global acceptance of integrative medicine, and modernization of traditional formulations through clinical validation.
The company is well-positioned to benefit from the growing wellness and preventive healthcare trends worldwide.

Risk Factors

Key challenges include regulatory scrutiny of traditional medicine claims in international markets, quality control complexities in herbal sourcing, and competition from modern pharmaceuticals.
The company also faces risks from raw material price volatility and potential generational shifts away from traditional medicine practices.

Competitive Landscape

Tong Ren Tang competes with other major Chinese pharmaceutical companies like Yunnan Baiyao and Tasly Pharmaceutical, but maintains competitive advantages through its unmatched 350+ year heritage, extensive product portfolio, and strong brand recognition. The company's imperial pharmacy legacy provides unique authenticity and trust in the traditional medicine market.